Alecensa 150 mg Capsule

Brand Name: Alecensa

Molecule: Alectinib

Strength: 150 mg

Quantity: 56 Capsules

Form: Capsule

Packaging Type: Bottle

Manufacturer/Marketed By: Roche

Country of Origin: Switzerland

Description

Alecensa 150 mg Capsule contains Alectinib, a targeted anticancer medicine used to treat ALK-positive metastatic non-small cell lung cancer (NSCLC). It helps slow tumor growth and spread under oncologist supervision.

Benefits

Targets ALK-driven cancer cells directly
Helps slow tumor growth and metastasis
Proven improvement in progression-free survival
Effective for brain metastases due to strong CNS penetration
Convenient oral dosing for long-term therapy

Indications and Usage

Alecensa 150 mg Capsule is indicated for:

ALK-positive metastatic non-small cell lung cancer (NSCLC)
First-line treatment or after progression on another ALK inhibitor

ALK-positive status must be confirmed through approved diagnostic testing.

How it Works

Alectinib blocks abnormal ALK signaling, a genetic mutation that drives cancer cell growth in certain lung cancers. By inhibiting this pathway, it slows tumor development, spread, and survival.

Dosage & Administration

Usual dose: 600 mg per day (150 mg × 4 capsules), divided into two doses
Take with food, at consistent times daily
Swallow capsules whole—do not crush or open
Continue until disease progression or unacceptable toxicity
Regular liver, kidney, heart rate, and blood tests are required

Use only under oncologist supervision.

Side Effects

Common side effects:

Fatigue or weakness
Constipation
Swelling in hands or feet
Muscle pain
Rash
Low red blood cell count

Serious side effects (seek urgent care):

Liver toxicity
Lung inflammation (pneumonitis)
Severe muscle damage (high CPK levels)
Slow or irregular heartbeat
Kidney dysfunction

Warning and Precaution

Not recommended during pregnancy or breastfeeding
Monitor for liver, lung, muscle, and heart-related side effects
Avoid driving if experiencing dizziness or vision changes
Inform doctor about all medications to prevent interactions
Report breathing difficulty, severe fatigue, jaundice, or muscle pain immediately